Key drivers of this growth include the rising incidence of degenerative bone diseases, diabetic ulcers, traumatic injuries, sports-related ...

Cardiovascular Reparative Medicine and Tissue Engineering (CRMTE) aims to develop future technologies and therapeutic strategies that will serve as treatment for cardiovascular disease. CRMTE includes ...

Dr. Johnson V. John, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been appointed as a ...

Organ failure impacts millions of patients each year and costs hundreds of billions of US Dollars. Over the last 30 years, scientists have utilized a combination of tools, methods, and molecules of ...

MIT engineers create a programmable drug patch that heals damaged heart tissue and restores cardiac function after a heart ...

A new strategy in tissue engineering has been developed: Tiny spherical microscaffolds are created in a high precision 3D printer. They are cultivated with living cells and then assembled. The cells ...

Upon analyzing the ECM, the researchers found glycosides, polysaccharides, and cellulose—the three main chemistries that have been used as biomaterial scaffolds. The seaweed scaffold was found to have ...

Japan Tissue Engineering (TSE:7774) remains unprofitable, but has managed to trim its losses by 16.1% per year over the past five years. With earnings forecast to jump 40.83% annually and the company ...

Human health is the Achilles heel of space travel. Researchers at ETH Zurich have now succeeded in printing complex muscle ...

Japan Tissue Engineering Co., Ltd. ( ($JP:7774) ) has issued an update. Japan Tissue Engineering Co., Ltd. reported a decline in financial ...